Skip to content

Arcutis Biotherapeutics, Inc. ARQT Capital investments accrued but not yet paid

Capital investments accrued but not yet paid at other companies

HTF
Heartflow, Inc. Common StockHTFL
$912K+15,100%
ESN
Essent GroupESNT
$85K
HWK
HawkinsHWKN
$1.71M+148%
EAT
Brinker InternationalEAT
$300K-98.7%
ALH
Alliance Laundry Holdings Inc.ALH
$2M-40.7%
Tidewater logo
TidewaterTDW
$0-100%

Other financials

Income statement

See full
Revenue$105.4M+60.1%
Gross profit$95.6M+67.7%
Operating income-$9.1M+62.9%
Net income-$11.3M+54.9%
EPS (diluted)-$0.09+55.0%

Balance sheet

See full
Cash & equivalents$35.1M-34.7%
Total debt$114.7M+3.5%
Total equity$189.6M+32.9%
Total assets$460.0M+33.7%

Cash flow

See full
Operating cash flow$2.2M+107%
CapEx--100%
Free cash flow$2.2M+107%

Valuation

See full
Market cap$3.29B+57.5%

Profitability

See full
Gross margin90.9%+2.5pp
Operating margin-12%-5.7pp
Net margin-13.9%-6.6pp
FCF margin-52.5%-21.9pp

Returns & leverage

See full
Return on equity-28.2%-13.0pp
Debt / equity0.6×-0.2×
Current ratio2.7×-0.9×

Where this comes from

Reported directly by Arcutis Biotherapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CapitalExpendituresIncurredButNotYetPaid.

The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arcutis Biotherapeutics, Inc.'s capital investments accrued but not yet paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arcutis Biotherapeutics, Inc.'s capital investments accrued but not yet paid?
Arcutis Biotherapeutics, Inc. (ARQT) reported capital investments accrued but not yet paid of $158K in Q1 2026.